Posted by Michael Wonder on 14 Dec 2022
More than 5,200 people could benefit after NICE broadens recommendation on chronic lung disease treatment
14 December 2022 - NICE broadens recommendation on chronic lung disease treatment.
NICE has today recommended that nintedanib esylate to treat idiopathic pulmonary fibrosis be extended to more people.
